Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $134845.0.

  • Mangoceuticals' Other Working Capital Changes rose 30453.9% to $134845.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $97236.0, marking a year-over-year increase of 19171.09%. This contributed to the annual value of -$63717.0 for FY2024, which is 1232.42% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Other Working Capital Changes is $134845.0, which was up 30453.9% from -$17596.0 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Other Working Capital Changes peaked at $283333.0 during Q1 2024, and registered a low of -$129363.0 during Q4 2023.
  • In the last 3 years, Mangoceuticals' Other Working Capital Changes had a median value of $21485.0 in 2023 and averaged $58228.1.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 135075.78% in 2024, then plummeted by 10621.04% in 2025.
  • Mangoceuticals' Other Working Capital Changes (Quarter) stood at -$129363.0 in 2023, then soared by 97.86% to -$2764.0 in 2024, then skyrocketed by 4978.62% to $134845.0 in 2025.
  • Its Other Working Capital Changes stands at $134845.0 for Q3 2025, versus -$17596.0 for Q2 2025 and -$17249.0 for Q1 2025.